Cure8 research brief
Cure8 research brief
Perceived stigma may affect how Black people with IBD view their care and whether they stick with medications, which can influence disease management and outcomes. Understanding these links can point to targets for improving equity in IBD care.
Black adults with IBD; clinicians treating racially diverse IBD patients; researchers and patient-advocacy groups focused on disparities.
This Digestive Diseases and Sciences article reports a survey-based study of perceived stigma among 1,142 Black adults with IBD (July–August 2022) and examines associations between stigma and outcomes including medication adherence and perception of care.
The authors found moderate levels of perceived stigma were common and were associated with differences in medication-taking behavior and poorer perception of care; mood measures were not significantly linked to stigma in adjusted models.
The study used a web-based questionnaire distributed with the advocacy group Color of Gastrointestinal Illnesses and analyzed associations using multivariable Poisson regression restricted to Black respondents. The paper is presented as journal research and the extracted text here is from the article abstract and metadata.
disparities research rather than a treatment intervention. It may help clinicians, researchers, and patient advocates understand how perceived stigma relates to care experience and self-reported medication use in this population.
This classification is based on the journal abstract and article metadata. The study is survey-based and reports associations; causal conclusions are not supported by the provided text.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: Pfizer Global Medical Grant
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.